NCT00691717View on ClinicalTrials.gov

Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Open-angle GlaucomaOular Hypertension
Interventions
DRUG

Anecortave Acetate Sterile Suspension, 30 mg/mL

Single administration by anterior juxtascleral depot

DRUG

Anecortave Acetate Sterile Suspension, 60 mg/mL

Single administration by anterior juxtascleral depot

DRUG

Anecortave Acetate Sterile Suspension, 75 mg/mL

Single administration by anterior juxtascleral depot

OTHER

Anecortave Acetate Vehicle

Single administration by anterior juxtascleral depot

Trial Locations (1)

29414

Charleston, Charleston

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY